Oxford Technology 3 VCT Plc – NAV Update
Oxford Technology 3 VCT Plc (“OT3”) Announces Unaudited Net Asset Value (“NAV”) Update of the Company from Third Quarter Figures Released to November 30, 2021 Based on Movements of its AIM-listed investments and a fee estimate.
As of February 23, 2022, the NAV has fallen by 16%, from 49.5 pence to 41.8 pence.
The share price of the two listed stocks fell – Arecor Therapeutics Plc (“Arecor”) (380p to 350p) and Scancell Holdings Plc (“Scancell”) (20p to 13p).
The valuations of the other holdings have remained unchanged for the purposes of this net asset value update. More complete results for the 12-month period ending February 28, 2022 will be announced in due course.
Shareholders should note that for every 10 pence per share change in Arecor’s offer price, the net asset value changes by approximately 0.7 pence per OT3 share. For every 1 pence per share change in Scancell’s offer price, the net asset value moves by approximately 0.7 pence per OT3 share.
The total number of ordinary shares in circulation is 6,254,596.
This announcement contains inside information as set out in the UK version of the Market Abuse Regulation No 596/2014, which forms part of English law under the EU (Withdrawal) Act 2018, as amended. Upon publication of this announcement via a regulatory information service, this information is now considered to be in the public domain.
February 24, 2022
Oxford Technology Management